One World Products, Inc.
For the period ended Sep 30, 2025. Filed Jan 2, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Jan 2, 2026
OWPCStored price and day change unavailable
What changed in Management’s Discussion and Analysis?
Read the current filingPrevious report: 10-Q
Period ended 2025-06-30; filed 2025-09-19.
0001493152-25-014319
Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONSCurrent report: 10-Q
Period ended 2025-09-30; filed 2026-01-02.
0001493152-26-000184
Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONSThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 56 previous paragraphs and 62 current paragraphs.
16 unchanged; 12 reworded; 34 added; 28 removed; 0 previous and 0 current paragraphs rearranged.
Tables are not compared: 5 previous and 4 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Added paragraphs (34)
Current report
On July 14, 2025, the Company completed the acquisition of certain assets of Eco Bio Plastics Midland, Inc. The accompanying condensed consolidated financial statements reflect the historical results of One World Products, Inc. and its subsidiaries for the periods presented. Unaudited pro forma financial information giving effect to the acquisition is presented separately for illustrative purposes only.
Current report
In July 2025, the Company’s Board of Directors and the Company’s majority shareholder approved a change in the Company’s corporate name to “Isiah Enterprises, Inc.” This change in corporate name will not become effective in the trading markets until such time as FINRA has approved such change.
Current report
Revenues
Current report
Revenues during the three months ending September 30, 2025, were $49,966, compared to $1,517 during the three months ending September 30, 2025, an increase of $48,449, or 3,194%. Revenues during the current period were generated by manufacturing sales of Eco Bio products, while revenues from the comparative period were attributable to CBD products.
Current report
Cost of Goods Sold
Current report
Cost of goods sold for the three months ending September 30, 2025, were $1,375, compared to $310 for the three months ending September 30, 2024, an increase of $1,065 or 344%. Cost of goods sold for the current period was from manufacturing compounding product consists primarily of additives while the costs for CBD products are finished goods sold. Our profit margin during the three months ended September 30, 2025, was 96% compared to 80% for the three months ending September 30, 2024.
Current report
Salaries, wages and benefits
Current report
Salaries, wages and benefits have been tracked separately since the acquisition of the Eco Bio Plastics Michigan operation. Wages, salaries, and benefits for the three months ending September 30, 2025, were $250,800. Such costs did not exist in the prior operations as the Company had no salaries, wages and benefits cash payments.
Current report
General and Administrative Expenses
Current report
General and administrative expenses for the three months ending September 30, 2025, were $17,150 compared to $203,242 during the three months ending September 30, 2024, a decrease of $186,092, or 92%. The expenses for the current period consisted primarily of office rent and travel costs. General and administrative expenses decreased primarily due to our focus on operations within the United States.
Current report
Professional Fees
Current report
Other Income (Expense)
Current report
Other income (expenses), on a net basis, for the three months ending September 30, 2025, were $5,642,883, compared to other expenses, on a net basis, for the three months ending September 30, 2024, of $362,968, an increase in other income of $6,005,851, or 1,655%. Other income (expense) for the three months ended September 30, 2025, primarily reflects a gain of $6,049,860 recognized in connection with the acquisition of Eco Bio Plastics Midland, Inc. The gain represents a bargain purchase under ASC 805, calculated as the excess of the fair value of net assets acquired over the purchase price, and was recognized in terms of earnings during the period. This gain was partially offset by interest expense of $258,135 associated with outstanding debt. There were no gains or losses related to foreign subsidiary deconsolidation during the period. Expenses in 2024 resulted from one-time charges related to a $22,359 loss on deconsolidation of foreign subsidiaries and $340,609 of interest expense, including $147,756 of stock-based finance costs on the amortization of debt discounts for the three months ended September 30, 2024. Depreciation expense of $148,001 related to the newly acquired fixed assets.
Current report
Net Income (Loss)
Current report
Net loss for the three months ending September 30, 2025, was $5,265,743, $0.44 per share, compared to $734,599 or a loss of $0.01 per share, during the three months ended September 30, 2024, an increase of $6,000,342, or 817%.
Current report
Results of Operations for the Nine Months Ended September 30, 2025, and 2024:
Current report
Revenues
Current report
Revenues during the nine months ended September 30, 2025 were $51,619, compared to $3,053 during the nine months ended September 30, 2025, a increase of $48,566, or 1591%. Revenues during the current period were generated by sales at our Eco Bio Plastics Michigan facility while 2024 sales were from our CBD product.
Current report
Cost of Goods Sold
Current report
Salaries, wages and benefits
Current report
Salaries, wages and benefits have been tracked separately since the acquisition of the Eco Bio Plastics Michigan operation. Wages, salaries, and benefits for the Nine months ending September 30, 2025, were $250,800. Such costs did not exist prior to the acquisition of Eco Bio Plastics Michigan in 2025.
Current report
General and Administrative Expenses
Current report
General and administrative expenses for the nine months ending September 30, 2025, were $202,503, compared to $552,874 during the nine months ending September 30, 2024, a decrease of $350,371, or 63%. The expenses for the current period consisted primarily of liability insurance premiums, utilities, operating expenses and other costs of operation of the plant.
Current report
Professional Fees
Current report
Other Income (Expense)
Current report
Other Income (Expense), on a net basis, for the nine months ending September 30, 2025, were $5,425,930, compared to other income (expense), on a net basis, of $(1,778,337) during the nine months ending September 30, 2024, an increase in net other income (expenses) of $7,204,267, or 405%. Other income (expense) for the nine months ended September 30, 2025, primarily reflects a gain of $6,049,860 recognized in connection with the acquisition of Eco Bio Plastics Midland, Inc. The gain represents a bargain purchase under ASC 805, calculated as the excess of the fair value of net assets acquired over the purchase price, and was recognized in terms of earnings during the period. This gain was partially offset by interest expense of $475,088 associated with outstanding debt. There were no gains or losses related to foreign subsidiary deconsolidation during the period. Depreciation expense of $148,001 related to the newly acquired fixed assets. The decrease is due primarily to the elimination of foreign operations and related debts.
Current report
Net Income (Loss)
Current report
Net Income for the nine months ending September 30, 2025, was $4,744,160, or less than $0.40 per share, compared to a loss of $3,300,680 or less than $0.30 per share, during the nine months ended September 30, 2024, an increase of $8,044,840, or 244%. The net income increased primarily due to a gain in connection with the acquisition of Eco Bio Plastics Midland, Inc. and related debt, stock-based compensation, the fair value of common stock issued to related parties as commitment shares on debt modifications and interest expense.
Current report
During the nine months ended September 30, 2025, net cash used in operating activities was $593,837, and $1,010,268, in the nine months ended September 30, 2024. The change was primarily attributable to non-cash adjustments, including the bargain purchase gain recognized in connection with the acquisition of Eco Bio Plastics Midland, Inc., which did not result in operating cash inflows, together with changes in working capital and operating results during the period.
Current report
Net Cash Used in Investing Activities
Current report
During the nine months ended September 30, 2025, net cash used in investing activities was $415,000 for the nine months ended September 30, 2025, and $75,000 in the nine months ended September 30, 2024. The change was due to cash used during the period for the acquisition of fixed assets in the Eco Bio Plastics Michigan purchase.
Current report
During the nine months ended September 30, 2025, net cash provided by financing activities was $1,135,000 and $1,208,500, in the nine months ended September 30, 2024. The current period consisted of increase in Notes Payable from affiliated shareholders. In the period ended September 30 2025 a series of restructuring notes payable accounted for the changes the nine months ended September 30, 2024.
Current report
Currently the Company manufactures products and provides research and development production studies under custom work orders. Net revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods or providing services and is recognized when performance obligations are satisfied under the terms of contracts with customers.
Current report
A performance obligation is deemed to be satisfied by the Company when control of the product or service is transferred to the customer. The transaction price of a contract, or the amount the Company expects to receive upon satisfaction of the performance obligation, is determined by reference to the contract’s terms and includes adjustments. If an estimate is required, these allowances are determined using the expected value method, which is typically based upon historical rates. The timing of revenue recognition for product is at a point in time.
Removed paragraphs (28)
Previous report
We are currently focused on research and development activities involving bio-sustainable solutions. These solutions enable automakers to reduce their carbon footprint and support environmental initiatives within the automotive supply chain. In October of 2024, we partnered with other companies in the automotive industry to produce 1,400 reusable hemp-based molded reusable totes, designed to move and protect automotive parts through the supply chain. We are actively seeking to raise capital and further research and development in this area. If successful, we intend to produce these hemp-based materials for a variety of applications, starting with automotive component applications.
Previous report
We also entered into a strategic partnership with Stephen Marley’s Kx Family Care in 2024 in which we purchased 2,000 units of CBD products, which we white labeled as Pro-11 and began selling online. There can be no assurances that this strategic partnership will generate significant revenues or be profitable for the Company.
Previous report
Recent Event – Acquisition of Eco Bio Plastics
Previous report
Asset Purchase Agreement. On June 4, 2025, the Company entered into a Letter of Intent (the “Eco Bio LOI”) with Eco Bio Plastics Midland, Inc. (“Eco Bio”).
Previous report
Further to the Eco Bio LOI, on July 11, 2025, the Company, EBPIE, LLC, a Michigan limited liability company wholly owned by the Company (“EBPIE”), and Eco Bio signed and closed an Asset Purchase Agreement (the “Eco Bio Asset Agreement”), pursuant to which EBPIE acquired substantially all of the assets of Eco Bio for a total of $515,000 in cash, with $415,000 being paid at the closing and $100,000 having been paid on the execution of the Eco Bio LOI and credited towards the total purchase price.
Previous report
Employment Agreement. On July 11, 2024, EBPIE entered into an Executive Employment Agreement (the “Saotome Agreement”) with Fukuji Saotome, pursuant to which Mr. Saotome will serve as EBPIE’s Chief Operating Officer. The initial term of the Saotome Agreement ends December 31, 2030, and renews automatically for successive 12-month terms, unless cancelled by either EBPIE or Mr. Saotome upon not less than 90-days’ written notice prior to the end of the then-current term. Under the Saotome Agreement, Mr. Saotome is to be compensated, as follows:
Previous report
Stock Option Grant Notice. On July 11, 2024, the Company entered into an Stock Option Grant Notice (the “Saotome Option Grant”) with Fukuji Saotome, pursuant to which the Company, pursuant to its 2019 Stock Incentive Plan, granted Mr. Saotome an option to purchase up to 5,000,000 shares (the “Saotome Option”) of the Company’s common stock at a per share exercise price of $0.13, with an expiration date of December 31, 2030. The Saotome Option vests on the following schedule: 20% on July 11, 2025; 20% on December 31, 2027; 20% on December 31, 2028; 20% on December 31, 2029; and 20% on December 31, 2030.
Previous report
New Business Focus
Previous report
With the acquisition of Eco Bio, a Midland, Michigan-based manufacturer of plant-based and biodegradable plastics and its developing industrial solutions business targeting the automotive market, we are now focused on industrial compounding food packaging, automotive, and consumer goods sectors.
Previous report
Revenues. Revenues during the three months ending June 30, 2025, were $282, compared to $1,254 during the three months ended June 30, 2024, an increase of $972. Revenues were generated by sales of our CBD product, which is a business segment of which we are not currently pursuing. Revenues in future periods will be from the operations of Eco Bio and our industrial hemp business activities.
Previous report
General and Administrative Expenses. General and administrative expenses for the three months ended June 30, 2025, were $86,685, compared to $150,785 during the three months ended June 30, 2024, a decrease of $64,100. The expenses for the current period consisted primarily of compensation expenses, office rent, advertising and travel costs. General and administrative expenses decreased primarily due to a decrease in costs related to closing and deconsolidating the South American operations. General and administrative expenses included non-cash, stock-based compensation of $86,685 and $150,785 during the three months ended June 30, 2025, and 2024, respectively.
Previous report
Professional fees decreased primarily due to decreased stock-based compensation issued to directors and consultants during the current period.
Previous report
Depreciation Expense. Depreciation expense for the three months ended June 30, 2025, and 2024 were zero due to the deconsolidation of OWP SAS at December 22, 2023.
Previous report
Other Income (Expense). Other expenses, on a net basis, for the three months ending June 30, 2025, were $94,847, compared to other expenses, on a net basis, for the three months ended June 30, 2024, of $491,632, a decrease in net other expenses of $404,445. Other expenses consisted of interest expenses of $94,847 for the three months ended June 30, 2025, and, for the three months ended June 30, 2024, $122,600 in loss in deconsolidation of foreign subsidiaries and $369,032 in interest expense. The large reduction in costs is primarily related to the completion of the deconsolidation of foreign subsidiaries.
Previous report
Net Loss.
Previous report
Net loss for the three months ending June 30, 2025, was $265,916, compared to $865,059, for the three months ended June 30, 2024, a decrease of $599,143. The net loss decreased primarily due to the absence of losses on early extinguishment ofdebt and to the loss on deconsolidation of foreign subsidiaries that was incurred in the prior period.
Previous report
Results of Operations for the Six Months Ended June 30, 2025 and 2024
Previous report
Revenues. Revenues during the six months ending June 30, 2025, were $1,653, compared to $1,536 during the six months ended June 30, 2024, an increase of $117. Revenues were generated by sales of our CBD product, which is a business segment of which we are not currently pursuing. Revenues in future periods will be from the operations of Eco Bio and our industrial hemp business activities.
Previous report
Cost of Goods Sold. Cost of goods sold for the six months ending June 30, 2025, were $328, compared to $278 for the six months ending June 30, 2024. COGS consists primarily of finished goods sold. Cost of goods sold in future periods will be from the operations of Eco Bio and our industrial hemp business activities
Previous report
General and Administrative Expenses. General and administrative expenses for the six months ended June 30, 2025, were $185,353, compared to $349,632 during the six months ended June 30, 2024, a decrease of $164,279. The expenses for the current period consisted primarily of compensation expenses, office rent, advertising and travel costs. General and administrative expenses decreased primarily due to a decrease in costs related to closing and deconsolidating the South American operations. General and administrative expenses included non-cash, stock-based compensation of $60,000 and $150,785 during the six months ended June 30, 2025, and 2024, respectively.
Previous report
Professional fees decreased primarily due to decreased stock-based compensation issued to directors and consultants during the current period.
Previous report
Depreciation Expense. Depreciation expense for the six months ended June 30, 2025, and 2024 were zero due to the deconsolidation of OWP SAS at December 22, 2023.
Previous report
Other Income (Expense). Other expenses, on a net basis, for the six months ending June 30, 2025, were $224,613, compared to other expenses, on a net basis, for the six months ending June 30, 2024, of $1,415,369, a decrease in net other expenses of $1,190,656. Other expenses consisted of interest expenses of $224,613 for the six months ended June 30, 2025, and, for the six months ended June 30, 2024, $724,086 in loss on extinguishment of debt, $220,272 in loss in deconsolidation of foreign subsidiaries and $471,011 in interest expense. The large reduction in costs is primarily related to the completion of the deconsolidation of foreign subsidiaries and the absence of losses on early extinguishment of debt.
Previous report
Net Loss. Net loss for the six months ending June 30, 2025, was $521,582, compared to $2,566,081, for the six months ended June 30, 2024, a decrease of $2,044,499. The net loss decreased primarily due to the absence of losses on early extinguishment of debt and to the loss on deconsolidation of foreign subsidiaries that was incurred in the prior period.
Previous report
During the six months ending June 30, 2025, net cash used in operating activities was $448,841 compared to net cash used in operating activities of $729,707 for the six months ended June 30, 2024. The cash used in operating activities was primarily attributable to our net loss.
Previous report
Net Cash Provided by Investing Activities
Previous report
During the six months ending June 30, 2025, net cash provided by The Investing activity in the current period is $0 compared to $75,000 of proceeds used for investing in Subsidiary.
Previous report
During the six months ending June 30, 2025, net cash provided by financing activities was $420,000 compared to net cash provided by financing activities of $1,208,500 for the six months ending June 30, 2024.
Reworded paragraphs (12)
Previous wording
Further, in collaboration with partners in the automotive industry, we have developed hemp-based molded containers for automotive part packaging applications, including reusable totes designed to move and protect automotive parts through the supply chain.
Current wording
During 2024, the Company began its new business model, first developing industrial hemp solutions for the automotive market. Then the Company began to focus increased efforts on research and development to help the automotive industry meet its goals of achieving carbon neutral manufacturing using renewable and recycled material solutions. In October of 2024, the Company, in collaboration with partners in the automotive industry, developed hemp-based molded containers for automotive part packaging applications and received an initial order for 1,400 units of these reusable totes, designed to move and protect automotive parts through the supply chain.
Previous wording
Eco Bio Plastics brings proprietary formulations and scalable manufacturing capacity that will support our transition into a vertically integrated sustainable materials company. Eco Bio’s advanced micronization and pelletization process enables the production of ultra-small, application-ready biofibers derived from organic matter, including agricultural byproducts, natural fibers and plant-based residues, that offer automotive, food and industrial clients a cost-effective, ESG-compliant alternative to traditional materials. In-house micronization allows Eco Bio to produce fine powder compounds ideal for coatings, polymer blends and talc-free formulations. Its patent-pending process produces the only pelletized bast fiber on the market, opening the door for additional sustainable fiber plastic compounds.
Current wording
With global demand surging for sustainable materials, and new regulatory incentives aligning with our strengths, Eco Bio Plastics is positioned to become one of the fastest-growing players in American green manufacturing. Eco Bio’s advanced micronizeation and pelletization process enables the production of ultra-small, application-ready biofibers derived from organic matter including agricultural byproducts, natural fibers, and plant-based residues - offering automotive, food, and industrial clients a cost-effective, ESG-compliant alternative to traditional materials. In-house micronizeation allows Eco Bio to produce fine powder compounds ideal for coatings, polymer blends, and talc-free formulations - meeting growing demand for recyclable, lightweight, and high-performance solutions across multiple sectors. Its patent-pending process produces the only pelletized bast fiber on the market, opening the door for additional sustainable fiber plastic compounds.
Previous wording
Professional Fees. Professional fees for the three months ending June 30, 2025, were $84,633, compared to $223,667 during the three months ending June 30, 2024, a decrease of $139,034. Professional fees included non-cash, stock-based compensation of $30,000 and $92,575 during the three months ended June 30, 2025 and 2024, respectively.
Current wording
Professional fees for the three months ending September 30, 2025, were $157,781, compared to $169,596 during the three months ending September 30, 2024, a decrease of $11,815, or 7%. Professional fees included non-cash, stock-based compensation of $21,564 and $147,367 during the three months ending September 30, 2025, and 2024, respectively. Professional fees increased primarily due to increased stock-based compensation being issued to consultants during the current period.
Previous wording
The following table summarizes selected items from the statement of operations for the six months ended June 30, 2025 and 2024.
Current wording
The following table summarizes selected items from the statement of operations for the nine months ended September 30, 2025 and 2024.
Previous wording
Cost of Goods Sold. Cost of goods sold for the three months ending June 30, 2025, were $33, compared to $229 for the three months ending June 30, 2024. COGS consists primarily of finished goods sold. Cost of goods sold in future periods will be from the operations of Eco Bio and our industrial hemp business activities
Current wording
Cost of goods sold for the nine months ending September 30, 2025, were $1,703, compared to $588 for the nine months ending September 30, 2025, an increase of $1,115, or 190%. Cost of goods sold at Eco Bio Plastics Michigan is from chemical additives used in compounding, while our CBD product consisted primarily of finished goods sold.
Previous wording
Professional Fees. Professional fees for the six months ended June 30, 2025, were $120,601, compared to $802,338 during the six months ending June 30, 2024, a decrease of $681,737. Professional fees included non-cash, stock-based compensation of $60,000 and $92,575 during the six months ended June 30, 2025 and 2024, respectively.
Current wording
Professional fees for the nine months ending September 30, 2025, were $278,383, compared to $971,934 during the nine months ending September 30, 2025, a decrease of $693,551, or 71%. Professional fees included non-cash, stock-based compensation of $267,452 and $100,000 during the nine months ending September 30, 2025, and 2024, respectively. Professional fees decreased due to a reduction in forces following the closing of operations outside United States.
Previous wording
The following is a summary of the Company’s cash flows provided by (used in) operating, investing, financing activities and effect of exchange rate changes on cash for the six months ended June 30, 2025, and 2024:
Current wording
The following is a summary of the Company’s cash flows provided by (used in) operating, investing, financing activities and effect of exchange rate changes on cash for the nine months ended September 30, 2025 and 2024:
Previous wording
As of June 30, 2025, our balance of cash on hand was $13,615 and we had negative working capital of $3,198,254 and an accumulated deficit of $31,386,280. We are too early in our development stage to project future revenue levels and may not be able to generate sufficient funds to sustain our operations for the next twelve months. Accordingly, we will need to raise additional cash to fund our operations. These factors raise substantial doubt about the Company’s ability to continue as a going concern.
Current wording
As of September 30, 2025, our balance of cash on hand was $168,620, and we had negative working capital of $3,953,402 and an accumulated deficit of $26,120,538. We are too early in our development stage to project future revenue levels and may not be able to generate sufficient funds to sustain our operations for the next twelve months. Accordingly, we will need to raise additional cash to fund our operations. These factors raise substantial doubt about the Company’s ability to continue as a going concern.
Previous wording
The condensed consolidated financial statements do not include any adjustments that might result from the outcome of any uncertainty regarding the Company’s ability to continue as a going concern. The condensed consolidated financial statements also do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classifications of liabilities that might be necessary should the Company be unable to continue as a going concern. Our ability to scale production and distribution capabilities and further increase the value of our brands is largely dependent on our success in raising additional capital.
Current wording
The condensed consolidated financial statements do not include any adjustments that might result from the outcome of any uncertainty regarding the Company’s ability to continue as a going concern. The condensed consolidated financial statements also do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classifications of liabilities that might be necessary should the Company be unable to continue as a going concern. Our ability to scale production and distribution capabilities and further increase the value of our products is largely dependent on our success in raising additional capital.
Previous wording
The Company recognizes revenue in accordance with ASC 606 — Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue from the commercial sales of products, licensing agreements and contracts to perform pilot studies by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied. The Company’s revenues consisted of the sale of our Pro-11 CBD rub cannisters.
Current wording
The Company recognizes revenue in accordance with ASC 606 — Revenue from Contracts with Customers. Under ASC 606, the Company previously recognized revenue from the commercial sales of products, licensing agreements and contracts to perform pilot studies by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied. The Company’s revenues in the current period consisted of the sale of our CBD rub, and in the prior period revenues consisted entirely of the sale of seeds. The sale of seeds included multi-element arrangements whereby the Company collected 50% of the sale upon delivery of the sales, and the remaining 50% upon the completion of the harvest, whether the seeds result in a successful crop, or not. In addition, the Company had a right of first refusal to purchase products resulting from the harvest.
Previous wording
Inventories are stated at the lower of cost or net realizable value. Cost is determined on a standard cost basis that approximates the first-in, first-out (FIFO) method. Appropriate consideration is given to obsolescence, excessive levels, deterioration, and other factors in evaluating net realizable value. Our CBD products consisted of finished goods, along with packaging.
Current wording
Inventories are stated at the lower of cost or net realizable value. Cost is determined on a standard cost basis that approximates the first-in, first-out (FIFO) method. Appropriate consideration is given to obsolescence, excessive levels, deterioration, and other factors in evaluating net realizable value. Our cannabis products consist of cannabis flower grown in-house, along with produced extracts and CBD derived products.
Previous wording
The Company accounts for equity instruments issued to employees and non-employees in accordance with the provisions of ASC 718 Stock Compensation (ASC 718). All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date of the fair value of the equity instrument issued is the earlier of the date on which the counterparty’s performance is complete or the date at which a commitment for performance by the counterparty to earn the equity instruments is reached because of sufficiently large disincentives for nonperformance.
Current wording
The Company accounts for equity instruments issued to employees and non-employees in accordance with the provisions of ASC 718 Stock Compensation (ASC 718). All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date of the fair value of the equity instrument issued is the earlier date on which the counterparty’s performance is complete or the date at which a commitment for performance by the counterparty to earn the equity instruments is reached because of sufficiently large disincentives for nonperformance.